During the past decade, Norton Cancer Institute Pharmacy, Downtown Pharmacy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Norton Cancer Institute Pharmacy, Downtown Pharmacy" are "Breast Cancer" (1 trials), "Castration Resistant Prostate Cancer (CRPC)" (1 trials), "Follicular Lymphoma (FL)" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Norton Cancer Institute Pharmacy, Downtown Pharmacy" in a lesser frequency.

Most popular intervention types in "Norton Cancer Institute Pharmacy, Downtown Pharmacy" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-06821497" (1 trials), "PF-06936308" (1 trials), "PF-0704091 + Fulvestrant (post CDK4/6)" (1 trials), "PF-07104091 + Fulvestrant (post CDK4/6)" (1 trials) and "PF-07104091 + palbociclib + fulvestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Norton Cancer Institute Pharmacy, Downtown Pharmacy" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Norton Cancer Institute Pharmacy, Downtown Pharmacy". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Norton Cancer Institute Pharmacy, Downtown Pharmacy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Norton Cancer Institute Pharmacy, Downtown Pharmacy, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".